BR9810458A - Solução, composição farmacêutica, e, cápsula de gelatina carregada lìquida - Google Patents

Solução, composição farmacêutica, e, cápsula de gelatina carregada lìquida

Info

Publication number
BR9810458A
BR9810458A BR9810458-6A BR9810458A BR9810458A BR 9810458 A BR9810458 A BR 9810458A BR 9810458 A BR9810458 A BR 9810458A BR 9810458 A BR9810458 A BR 9810458A
Authority
BR
Brazil
Prior art keywords
solution
pharmaceutical composition
present
gelatin capsule
liquid charged
Prior art date
Application number
BR9810458-6A
Other languages
English (en)
Inventor
Alan Frank Parr
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of BR9810458A publication Critical patent/BR9810458A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"SOLUçãO, COMPOSIçãO FARMACêUTICA, E, CáPSULA DE GELATINA CARREGADA LìQUIDA". A presente invenção descreve uma nova solução compreendendo uma quantidade terapeuticamente eficaz de um aza esteróide farmaceuticamente ativo, e um éster de ácido graxo de glicerol ou propileno glicol. Em outro aspecto, a presente invenção descreve uma composição farmacêutica compreendendo a solução da invenção. Em outro aspecto, a presente invenção descreve uma cápsula de gelatina carregada com a composição da presente invenção.
BR9810458-6A 1997-08-19 1998-08-17 Solução, composição farmacêutica, e, cápsula de gelatina carregada lìquida BR9810458A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9717428.8A GB9717428D0 (en) 1997-08-19 1997-08-19 Pharmaceutical composition
PCT/EP1998/005194 WO1999008666A2 (en) 1997-08-19 1998-08-17 Pharmaceutical composition comprising an azateroid

Publications (1)

Publication Number Publication Date
BR9810458A true BR9810458A (pt) 2000-09-05

Family

ID=10817619

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810458-6A BR9810458A (pt) 1997-08-19 1998-08-17 Solução, composição farmacêutica, e, cápsula de gelatina carregada lìquida

Country Status (15)

Country Link
EP (1) EP1007010A2 (pt)
JP (1) JP2002511101A (pt)
KR (1) KR20010014080A (pt)
CN (1) CN1263461A (pt)
AR (1) AR016629A1 (pt)
AU (1) AU9343098A (pt)
BR (1) BR9810458A (pt)
CA (1) CA2295016A1 (pt)
CO (1) CO4960657A1 (pt)
GB (1) GB9717428D0 (pt)
MA (1) MA26531A1 (pt)
PE (1) PE105699A1 (pt)
TR (1) TR199903209T2 (pt)
WO (1) WO1999008666A2 (pt)
ZA (1) ZA987392B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS6633A (is) * 2002-11-22 2004-05-23 Omega Farma Ehf. Samsetningar af fínasteríð töflum
KR101152470B1 (ko) 2003-08-13 2012-06-01 바이오콘 리미티드 치료제용 마이크로-입자 지방산 염 고형 투약 제형
WO2005066195A1 (de) * 2004-01-02 2005-07-21 Pharmacon Forschung Und Beratung Gmbh Verfahren zur herstellung von 1,2-ungesättigten azasteroiden
WO2006055659A2 (en) * 2004-11-15 2006-05-26 Smithkline Beecham Corporation Fixed dose combination op dutasteride and tamsulosin
WO2010117873A2 (en) 2009-04-06 2010-10-14 Banner Pharmacaps, Inc. Progesterone solutions for increased bioavailability
ES2385240B1 (es) 2010-07-26 2013-09-23 Gp-Pharm, S.A. Cápsulas de principios activos farmacéuticos y ácidos grasos poliinsaturados para el tratamiento de enfermedades de la próstata.
US8900631B2 (en) 2011-04-28 2014-12-02 Health Science Funding, LLC Dosage form to increase prasterone bioavailability
CN103169712B (zh) * 2011-12-20 2017-10-27 重庆华邦制药有限公司 提高生物利用度的度他雄胺制剂及其制备方法
WO2014002015A1 (en) 2012-06-25 2014-01-03 Ranbaxy Laboratories Limited Pharmaceutical composition comprising dutasteride
EP2949319A1 (en) 2014-05-26 2015-12-02 Galenicum Health S.L. Pharmaceutical compositions comprising an active agent
KR101679992B1 (ko) 2015-12-31 2016-11-28 주식회사 유유제약 프로필렌글리콜 모노라우레이트를 포함하는 두타스테리드의 약학적 조성물 및 이의 제조 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571817A (en) * 1984-02-27 1996-11-05 Merck & Co., Inc. Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones]
DE3607651A1 (de) * 1986-03-06 1987-09-10 Schering Ag Kombination von aromatasehemmer und testosteron-5(alpha)-reduktase-hemmer
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
TW408127B (en) * 1993-09-17 2000-10-11 Glaxo Inc Androstenones
US5550134A (en) * 1995-05-10 1996-08-27 Eli Lilly And Company Methods for inhibiting bone loss

Also Published As

Publication number Publication date
CO4960657A1 (es) 2000-09-25
PE105699A1 (es) 1999-11-25
MA26531A1 (fr) 2004-12-20
CA2295016A1 (en) 1999-02-25
WO1999008666A2 (en) 1999-02-25
GB9717428D0 (en) 1997-10-22
JP2002511101A (ja) 2002-04-09
TR199903209T2 (xx) 2000-05-22
WO1999008666A3 (en) 1999-04-15
CN1263461A (zh) 2000-08-16
EP1007010A2 (en) 2000-06-14
ZA987392B (en) 2000-02-17
KR20010014080A (ko) 2001-02-26
AU9343098A (en) 1999-03-08
AR016629A1 (es) 2001-07-25

Similar Documents

Publication Publication Date Title
NZ236823A (en) Topical pharmaceutical and cosmetic compositions containing a salt of cholanic acid, a lipid and optionally a pharmaceutically or cosmetically active substance
DE3686936D1 (de) Am zielorgan wirkendes enterales abgabesystem.
BR9810458A (pt) Solução, composição farmacêutica, e, cápsula de gelatina carregada lìquida
DE69313849D1 (de) Pharmazeutische zusammensetzungen enthaltend nsaid und gallensaeuren
TNSN98229A1 (fr) Formulation pharmaceutique orale a liberation prolongee
NO975218D0 (no) Behandling av inflammatorisk tarmsykdom ved bruk av orale doseringsformer av omega-3-polyumettede syrer
TR199701170T1 (xx) Beklometazon dipropionat i�in �l��lm�� doz inhaleri.
DE69531934D1 (de) Hydrophobe arzneistoffabgabesysteme
ATE109659T1 (de) Arzneimittelzusammensetzungen.
DE69409969D1 (de) Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen
CA2134196A1 (en) Pharmaceutical preparation and process for its manufacture
FR2714830B1 (fr) Composition contenant des acides nucléiques, préparation et utilisations.
IL112664A (en) 4-amino derivatives of mycophenolic acid their preparation and pharmaceutical compositions containing them
ATE212351T1 (de) Androsten-derivate
HUP9701111A2 (hu) Töltőanyag lágy zselatin kapszula gyógyszeradagolási formához
BR9810285A (pt) Solução, composição farmacêutica, e, cápsula de gelatina.
MY101919A (en) Pharmaceutical compositions
DE59711908D1 (de) Verfahren zur Herstellung von Salzen von Säuregruppen tragenden pharmazeutischen Wirkstoffen
MY120521A (en) Pharmaceutical microspheres of valproic acid for oral administration.
DE69632533D1 (de) Intrapulmonare verabreichung vom hematopoietischem medikament
KR860000867A (ko) 급성 방사선 증후군 발현억제 및 패혈증 발현억제의 방법 및 그 조성물
FR2753376B1 (fr) Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
NO932236L (no) Farmasoeytisk preparat inneholdende probukol med forhoeyet biotilgjengelighet
BE1002024A6 (fr) Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.
RU95113437A (ru) (h±)-сложный этиловый эфир транс-2-диметиламино-1-фенил-3-циклогексентранс-1-карбоновой кислоты в виде первичного ортофосфата и твердая фармацевтическая композиция с обезболивающей активностью

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired